INSR and Obesity: Studies of rare patients with mutations affecting the insulin receptor (INSR) or which interrupt signalling downstream of it have provided insight into the pathogenesis of insulin resistance and consequent dyslipidaemia or hepatic lipid accumulation in common obesity [93].